Early experience with sequential intravesical gemcitabine and docetaxel for micropapillary variant non-muscle invasive bladder cancer.
Mohamad Abou ChakraIan M McElreeVignesh T PackiamSarah L MottMichael A O'Donnell
Published in: Urologic oncology (2024)
Gem/Doce with Val/Doce rescue appears to have activity against carefully selected non-muscle invasive MPUC with favorable histology. Larger prospective trials are needed to validate these results.